Trials / Completed
CompletedNCT00350168
Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Patients With Stage II Hypertension
An 8-week Multicenter Study to Evaluate the Efficacy and Safety of Orally Administered Valsartan/Amlodipine Combination Based Therapy Versus Amlodipine Monotherapy in Patients With Stage II Hypertension
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 647 (actual)
- Sponsor
- Novartis · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The purpose of this study is to evaluate the blood pressure lowering effects of a valsartan/amlodipine combination treatment and amlodipine monotherapy for the treatment of stage II hypertensive patients (MSSBP ≥ 160 mmHg).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | valsartan + amlodipine |
Timeline
- Start date
- 2006-06-01
- Primary completion
- 2007-04-01
- Completion
- 2007-04-01
- First posted
- 2006-07-10
- Last updated
- 2016-11-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00350168. Inclusion in this directory is not an endorsement.